Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | CDC25B | P30305 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | FADS1 | O60427 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CCR4 | P51679 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16760997 | 0.89 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL21645599 | 0.88 | HPRT1 (0.61) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL25433150 | 0.85 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL6541282 | 0.85 | HPRT1 (0.64) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL9572742 | 0.85 | HPRT1 (0.64) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL49213 | 0.85 | HSD17B10 (0.74) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL4849433 | 0.83 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL1921580 | 0.83 | HSD17B10 (0.71) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| SCHEMBL8500339 | 0.83 | HSD17B10 (0.71) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 | |
| Ammonia Solution, Strong SCHEMBL11586421 | 0.83 | HSD17B10 (0.71) | ALDH1A1HSD17B10CDC25BCYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022729-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| WO-2022131768-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | 솔루스첨단소재 주식회사 | 2022-06-23 | — | — | WO | disclosed |
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022729-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, VDAC2, ORAI2 | ALDH1A1 1855/4885HSD17B10 3125/4885CDC25B 1824/4885 |
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | PIEZO1, ORAI2, VDAC2 | ALDH1A1 1529/4885HSD17B10 3019/4885CDC25B 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.